Log in to save to my catalogue

O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment:...

O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2723818802

O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment: pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis

About this item

Full title

O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment: pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis

Publisher

London: BMJ Publishing Group Ltd

Journal title

Frontline gastroenterology, 2022-04, Vol.13 (Suppl 1), p.A8-A9

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Introduction/BackgroundProgressive familial intrahepatic cholestasis (PFIC) is a group of inherited paediatric cholestatic liver diseases. In the phase 3 PEDFIC 1 and PEDFIC 2 studies, odevixibat, an ileal bile acid transporter inhibitor, reduced serum bile acids (sBAs) and improved pruritus in patients with PFIC.AimUsing pooled data from PEDFIC 1...

Alternative Titles

Full title

O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment: pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2723818802

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2723818802

Other Identifiers

ISSN

2041-4137

E-ISSN

2041-4145

DOI

10.1136/flgastro-2022-bspghan.12

How to access this item